SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from PRECISION OPTICS CORPORATION, (POCI) — Jun 15, 2009

PRECISION OPTICS CORPORATION, INC.
Date: June 15, 2009 · CIK: 0000867840 · Accession: 0001104659-09-038206

AI Filing Summary & Sentiment

File numbers found in text: 333-156258

Referenced dates: June 9, 2009

Date
June 15, 2009
Author
/s/
Form
CORRESP
Company
PRECISION OPTICS CORPORATION, INC.

Letter

United States Securities and Exchange Commission Division of Corporation Finance Mary Beth Breslin Re: Precision Optics Corporation, Inc. File No. 333-156258

Dear Ms. Breslin:

I am securities counsel for Precision Optics Corporation, Inc. (the “Company”). Set forth below is the Company’s response to the comment received from the staff of the Securities and Exchange Commission (the “Staff”) in their letter dated June 9, 2009.

Comment 1. Please expand your prospectus to disclose your response to prior comment 2 that the waiver was oral and to clarify the duration of the waiver. See also Regulation S-K Compliance and Disclosure Interpretation question and answer 146.04 available on the Commission’s web site at http://www.sec.gov/divisions/corpfin/guidance/reg-kinterp.htm.

Response 1. The Company proposes to revise the disclosure in the registration statement as follows:

Page 2- the fourth paragraph on the page:

As a result of the June 25, 2008 transaction described above, certain anti-dilution provisions were triggered and we were obligated to issue 181,821 additional shares upon the exercise of the warrants issued February 1, 2007. Additionally, the exercise price of the warrants was reduced from $8.00 to $5.50. Pursuant to the February 1, 2007 Registration Rights Agreement, we are registering certain of these additional shares in this registration statement to which this prospectus forms a part. Mr. Pitlor, our Director, has orally agreed to waive his registration rights as they pertain to this registration statement. We believe Mr. Pitlor’s waiver will extend as long as it is in the best interests of our Company to delay the registration of Mr. Pitlor’s shares.

Page 13 — footnotes at the top of the page:

(3) The 18,182 shares of common stock underlying warrants issued to Mr. Pitlor as a result of the June 25, 2008 transaction are not being registered in this registration statement. Mr. Pitlor has orally agreed to waive his registration rights

with respect to these shares. We believe Mr. Pitlor’s waiver will extend as long as it is in the best interests of our Company to delay the registration of Mr. Pitlor’s shares.

The Company respectfully requests that the Staff permit the Company to make the proposed edits in the final prospectus filed pursuant to Rule 424.

If you have further questions or comments, please feel free to contact us. We are happy to cooperate in any way we can.

Regards,
/s/
Amy M. Trombly

Show Raw Text
CORRESP
1
filename1.htm

  1320
  Centre Street, Suite 202

  Newton, MA 02459

  Phone: 617-243-0060

  Fax: 617-243-0066

June 15, 2009

United States Securities
and Exchange Commission

Division of Corporation
Finance

100 F Street, N.E., Mail
Stop 3030

Washington, DC  20549

  Attn:

  Mary
  Beth Breslin

  Re:

  Precision
  Optics Corporation, Inc.

  File
  No. 333-156258

Dear
Ms. Breslin:

I
am securities counsel for Precision Optics Corporation, Inc. (the “Company”).  Set forth below is the Company’s response to
the comment received from the staff of the Securities and Exchange Commission
(the “Staff”) in their letter dated June 9, 2009.

Comment 1.           Please expand
your prospectus to disclose your response to prior comment 2 that the waiver
was oral and to clarify the duration of the waiver.  See also Regulation S-K Compliance and
Disclosure Interpretation question and answer 146.04 available on the
Commission’s web site at
http://www.sec.gov/divisions/corpfin/guidance/reg-kinterp.htm.

Response
1.                               The Company proposes to revise the
disclosure in the registration statement as follows:

Page 2- the fourth
paragraph on the page:

As a result of the June 25,
2008 transaction described above, certain anti-dilution provisions were
triggered and we were obligated to issue 181,821 additional shares upon the
exercise of the warrants issued February 1, 2007.  Additionally, the exercise price of the
warrants was reduced from $8.00 to $5.50.
Pursuant to the February 1, 2007 Registration Rights Agreement, we
are registering certain of these additional shares in this registration
statement to which this prospectus forms a part.  Mr. Pitlor, our Director, has orally
agreed to waive his registration rights as they pertain to this registration
statement.  We believe Mr. Pitlor’s
waiver will extend as long as it is in the best interests of our Company to
delay the registration of Mr. Pitlor’s shares.

Page 13 — footnotes
at the top of the page:

(3) The 18,182
shares of common stock underlying warrants issued to Mr. Pitlor as a
result of the June 25, 2008 transaction are not being registered in this
registration statement.  Mr. Pitlor
has orally agreed to waive his registration rights

with respect to these
shares.  We believe Mr. Pitlor’s
waiver will extend as long as it is in the best interests of our Company to
delay the registration of Mr. Pitlor’s shares.

The Company respectfully
requests that the Staff permit the Company to make the proposed edits in the
final prospectus filed pursuant to Rule 424.

If you have further
questions or comments, please feel free to contact us.  We are happy to cooperate in any way we can.

  Regards,

  /s/
  Amy M. Trombly